# Albania and Armenia meet hepatitis B control targets for children

> WHO says country serosurveys found no hepatitis B surface-antigen-positive children aged 6–8 in Albania and Armenia, validating both countries against regional control targets.

- Canonical URL: https://newsverum.com/en/news/albania-armenia-hepatitis-b-child-control-targets-2026
- Publisher: Newsverum
- Section: Health
- Published: 2026-10-13T02:11:42+00:00
- Updated: 2026-10-13T02:11:42+00:00
- Source review period: 2026-04-10
- Other editions: [Türkçe](https://newsverum.com/tr/news/albania-armenia-hepatitis-b-child-control-targets-2026.md), [العربية](https://newsverum.com/ar/news/albania-armenia-hepatitis-b-child-control-targets-2026.md), [Français](https://newsverum.com/fr/news/albania-armenia-hepatitis-b-child-control-targets-2026.md), [Español](https://newsverum.com/es/news/albania-armenia-hepatitis-b-child-control-targets-2026.md), [Deutsch](https://newsverum.com/de/news/albania-armenia-hepatitis-b-child-control-targets-2026.md), [Português](https://newsverum.com/pt/news/albania-armenia-hepatitis-b-child-control-targets-2026.md)

*The source does not state the event date; the period shown is the source review period.*

WHO Europe said Albania and Armenia met the hepatitis B control targets in its 2022–2030 regional action plans. The European Technical Advisory Group of Experts on Immunization (ETAGE) validated the milestone after assessment of country reports and recommendations from its hepatitis B working group at its sixth meeting on 10 April 2026. Country serosurveys found no positive hepatitis B surface-antigen results among tested children aged 6–8; WHO described this as an estimated prevalence of 0%.

The finding is limited to the age group and serosurveys described in the release; it does not mean hepatitis B has been eliminated from either country. WHO attributed the progress to more than two decades of vaccination and measures to prevent transmission from mother to child, including timely birth-dose vaccination. The report does not provide sample sizes or separate serosurvey estimates for the two countries.

## Data

### WHO validation based on hepatitis B serosurveys in children

The child serosurvey finding reported by WHO is shown together for the two countries; separate country estimates were not provided.

Methodology: Scoped to the serosurvey statement in WHO/Europe’s 12 October 2026 release; the published text did not give sample sizes.

| Population group | HBsAg positivity in children aged 6–8 | Scope stated by source |
|---|---|---|
| Country serosurveys of children aged 6–8 in Albania and Armenia, reported together. | 0 | WHO reports no positive HBsAg results and estimated prevalence of 0%; no separate country estimates or sample sizes are given. |

Sources: <https://www.who.int/europe/news/item/12-10-2026-albania-and-armenia-achieve-hepatitis-b-control-milestone--strengthening-the-who-european-region-s-path-to-elimination> · Download data: [JSON](https://newsverum.com/api/v1/articles/albania-armenia-hepatitis-b-child-control-targets-2026/data/source-measurements?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/albania-armenia-hepatitis-b-child-control-targets-2026/data/source-measurements?lang=en&format=csv)

## Sources

- [WHO/Europe](<https://www.who.int/europe/news/item/12-10-2026-albania-and-armenia-achieve-hepatitis-b-control-milestone--strengthening-the-who-european-region-s-path-to-elimination>) (Source checked: 2026-10-13; Published: 2026-10-12)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)